Viewing StudyNCT00004037



Ignite Creation Date: 2024-05-05 @ 11:21 AM
Last Modification Date: 2024-10-26 @ 9:04 AM
Study NCT ID: NCT00004037
Status: TERMINATED
Last Update Posted: 2013-04-11
First Post: 1999-12-10

Brief Title: Docetaxel in Treating Patients With Recurrent or Refractory Ovarian or Primary Peritoneal Cancer
Sponsor: Gynecologic Oncology Group
Organization: GOG Foundation

Conditions & Keywords Data

Conditions:
Name
Primary Peritoneal Cavity Cancer
Ovarian Cancer
Keywords:
Name View
primary peritoneal cavity cancer View
stage IV ovarian epithelial cancer View
recurrent ovarian epithelial cancer View